1. Home
  2. ACAD vs OSCR Comparison

ACAD vs OSCR Comparison

Compare ACAD & OSCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$22.53

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Oscar Health Inc.

OSCR

Oscar Health Inc.

HOLD

Current Price

$18.33

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACAD
OSCR
Founded
1993
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Accident &Health Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.8B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
ACAD
OSCR
Price
$22.53
$18.33
Analyst Decision
Buy
Hold
Analyst Count
22
8
Target Price
$30.55
$16.88
AVG Volume (30 Days)
1.3M
5.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
69.12
N/A
EPS
2.30
N/A
Revenue
$726,437,000.00
$11,701,427,000.00
Revenue This Year
$18.80
$63.89
Revenue Next Year
$11.70
$5.30
P/E Ratio
$9.64
N/A
Revenue Growth
40.45
27.50
52 Week Low
$14.45
$10.69
52 Week High
$28.35
$23.80

Technical Indicators

Market Signals
Indicator
ACAD
OSCR
Relative Strength Index (RSI) 54.22 77.57
Support Level $20.80 $12.54
Resistance Level $22.97 $19.43
Average True Range (ATR) 0.61 0.77
MACD 0.09 0.27
Stochastic Oscillator 86.89 99.66

Price Performance

Historical Comparison
ACAD
OSCR

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

About OSCR Oscar Health Inc.

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

Share on Social Networks: